ANDROSTANOLONE PROPIONATE
UNII F06YUT08U8

Substance Identification & Data

This profile provides standardized clinical and technical data for Androstanolone Propionate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) F06YUT08U8.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 855-22-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
F06YUT08U8
CAS Registry Number
855-22-1
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ANDROSTANOLONE PROPIONATE
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C22H34O3
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
XTAARPJDFFXHGH-GRPBBMKTSA-N
Line notation for describing the chemical structure and connectivity of atoms.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
PubChem CID
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
[C@]12([C@]([C@@]3(CC[C@@]4([C@@]([C@]3(CC1)[H])(CCC(=O)C4)C)[H])[H])(CC[C@@H]2OC(=O)CC)[H])C

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Androstanolone Propionate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

5.ALPHA.-ANDROSTAN-17.BETA.-OL-3-ONE PROPIONATE
5.ALPHA.-DIHYDROTESTOSTERONE PROPIONATE
ANDROSTANOLONE PROPIONATE
DIHYDROTESTOSTERONE 17.BETA.-PROPIONATE
DIHYDROTESTOSTERONE PROPIONATE
STANOLONE PROPIONATE

Systematic Nomenclature

ANDROSTAN-3-ONE, 17-(1-OXOPROPOXY)-, (5.ALPHA.,17.BETA.)-